MX384123B - Nutrición infantil para el mejoramiento en la sensibilidad a la insulina más adelante en la vida. - Google Patents

Nutrición infantil para el mejoramiento en la sensibilidad a la insulina más adelante en la vida.

Info

Publication number
MX384123B
MX384123B MX2016006882A MX2016006882A MX384123B MX 384123 B MX384123 B MX 384123B MX 2016006882 A MX2016006882 A MX 2016006882A MX 2016006882 A MX2016006882 A MX 2016006882A MX 384123 B MX384123 B MX 384123B
Authority
MX
Mexico
Prior art keywords
life
nutrition
children
insulin sensitivity
improving insulin
Prior art date
Application number
MX2016006882A
Other languages
English (en)
Other versions
MX2016006882A (es
Inventor
Catherine Mace
Florence Blancher
Yassaman Shahkhalili Dulloo
Original Assignee
Soc Des Produits Nestle S A Star
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc Des Produits Nestle S A Star filed Critical Soc Des Produits Nestle S A Star
Publication of MX2016006882A publication Critical patent/MX2016006882A/es
Publication of MX384123B publication Critical patent/MX384123B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1524—Inert gases, noble gases, oxygen, aerosol gases; Processes for foaming
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Pediatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a una composición nutritiva para usarse en el tratamiento, la prevención y/o la reducción del riesgo de un trastorno de síndrome metabólico que aparece más adelante en la vida, en donde la composición nutritiva comprende caseína.
MX2016006882A 2013-11-29 2014-11-27 Nutrición infantil para el mejoramiento en la sensibilidad a la insulina más adelante en la vida. MX384123B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13195014 2013-11-29
PCT/EP2014/075831 WO2015078974A1 (en) 2013-11-29 2014-11-27 Infant nutrition for improvement in insulin sensitivity later in life

Publications (2)

Publication Number Publication Date
MX2016006882A MX2016006882A (es) 2016-08-17
MX384123B true MX384123B (es) 2025-03-14

Family

ID=49679400

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016006882A MX384123B (es) 2013-11-29 2014-11-27 Nutrición infantil para el mejoramiento en la sensibilidad a la insulina más adelante en la vida.

Country Status (8)

Country Link
US (1) US10821150B2 (es)
EP (1) EP3082472A1 (es)
CN (1) CN105578904A (es)
AU (1) AU2014356485A1 (es)
MX (1) MX384123B (es)
PH (1) PH12016500950A1 (es)
RU (1) RU2694827C1 (es)
WO (1) WO2015078974A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108777996A (zh) * 2016-04-11 2018-11-09 雀巢产品技术援助有限公司 提供代谢有益效果的婴儿营养
MX2021005668A (es) * 2018-11-30 2021-06-15 Nestle Sa Composicion nutricional infantil para usar en el mejoramiento de la maduracion pancreatica y la biosintesis de insulina.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040102377A1 (en) 2001-04-10 2004-05-27 Irene Perrin Method and composition for prophylaxis of diabetes
WO2008054192A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
EP1932437A1 (en) * 2006-12-15 2008-06-18 Nestec S.A. Infant formula
EP2011506A1 (en) * 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
MY159212A (en) * 2008-09-02 2016-12-30 Nutricia Nv Nutritional compositions with coated lipid globules
US9480670B2 (en) * 2009-04-01 2016-11-01 Nestec S.A. Reduction of risk of obesity
EP2413952B2 (en) * 2009-04-03 2019-10-02 Société des Produits Nestlé S.A. Improvement in promotion of healthy catch-up growth
WO2010119088A2 (en) * 2009-04-15 2010-10-21 Bodo Melnik Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity
EP2583562A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for infants at risk of obesity or diabetes
US20140308393A1 (en) * 2011-12-27 2014-10-16 Abbott Laboratories Reduced calorie infant formulas containing specific whey to casein ratios

Also Published As

Publication number Publication date
EP3082472A1 (en) 2016-10-26
RU2694827C1 (ru) 2019-07-17
AU2014356485A1 (en) 2016-03-03
MX2016006882A (es) 2016-08-17
US20160296585A1 (en) 2016-10-13
US10821150B2 (en) 2020-11-03
PH12016500950A1 (en) 2016-06-27
CN105578904A (zh) 2016-05-11
WO2015078974A1 (en) 2015-06-04

Similar Documents

Publication Publication Date Title
CY1121153T1 (el) Παραγωγα εξενδινης-4 ως διπλοι glp1/gιp- ή τριγωνικοι αγωνιστες glp1/gιp/γλυκαγονης
MX2016015997A (es) Preparacion y uso de beta-d-nicotinamida ribosido cristalina.
MX2014015423A (es) Analogos de peptido de exedina-4.
CU20140082A7 (es) Pirimidinas y triazinas fusionadas sustituidas y sus uso
BR112016022465A2 (pt) agonistas de receptores de glp-1/glucagon duplo peptídicos derivados de exendina-4
AR098738A1 (es) Análogos del péptido exendina-4 no acilados
PH12015500688A1 (en) Exendin-4 derivatives as dual glp1/glucagon agonists
EA201692477A1 (ru) Композиции и способы применения для лечения метаболических расстройств
BR112016024319A2 (pt) métodos para aumentar os níveis de hemácias e tratar anemia falciforme
GT201600002A (es) Bencil-1h-pirazolo[3,4-b]piridinas y su uso
MX390084B (es) Moduladores del receptor p2x3 y p2x2/3 de diaminopirimidina para usarse en el tratamiento de la tos.
PH12016500774A1 (en) Nutritional composition for use in reducing metabolic stress in infants, decreasing gut permeability and approximating growth rate of breast-fed infants
EA201791611A1 (ru) Лечение пациентов детского возраста с сахарным диабетом 2 типа с помощью ликсисенатида
BR112017003644A2 (pt) métodos de tratamento de distúrbios do sono e para regular produção de melatonina.
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
MX382374B (es) Nutrición infantil que proporciona beneficios metabólicos.
PH12017500084A1 (en) Vitamin b2 and its use
PH12016500950A1 (en) Infant nutrition for improvement in insulin sensitivity later in life
PH12016501947A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
GEP20207145B (en) Combination of trazodone and gabapentin for the treatmen
MX375398B (es) Composición para la administración oral de magnesio en asociacion con una composicion para tratar la diabetes tipo 2 o las complicaciones de la misma.
UA89713U (ru) Способ ранней реабилитации детей после перенесенной внегоспитальной пневмонии
PH12016501919A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
UA86152U (ru) Способ лечения больных хроническим гепатитом с, которые имеют противопоказания к интерферонотерапии, и/или нон-респондеров
PL406123A1 (pl) Portal internetowy: Twarzą w Twarz